PHARMATHENE, INC 4
4 · PHARMATHENE, INC · Filed Jan 5, 2017
Insider Transaction Report
Form 4
St Peter Steven
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001 per share
2017-01-04$2.59/sh+10,000$25,900→ 145,004 total - Exercise/Conversion
Common Stock, par value $0.0001 per share
2017-01-04$2.47/sh+20,000$49,400→ 165,004 total - Exercise/Conversion
Common Stock, par value $0.0001 per share
2017-01-04$3.11/sh+20,000$62,200→ 185,004 total - Exercise/Conversion
Stock Option (right to buy)
2017-01-04−20,000→ 0 totalExercise: $2.47From: 2009-08-05Exp: 2019-08-05→ Common Stock (20,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2017-01-04−20,000→ 0 totalExercise: $2.20From: 2017-06-01Exp: 2026-05-31→ Common Stock (20,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2017-01-04−10,000→ 0 totalExercise: $2.59From: 2009-03-09Exp: 2018-06-13→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock, par value $0.0001 per share
2017-01-04$2.20/sh+20,000$44,000→ 205,004 total - Exercise/Conversion
Stock Option (right to buy)
2017-01-04−20,000→ 0 totalExercise: $3.11From: 2012-06-23Exp: 2021-06-23→ Common Stock (20,000 underlying)